Amedisys Inc (NASDAQ: AMED) stock closed at 93.92 per share at the end of the most recent trading day (a 0.4% change compared to the prior day closing price) with a volume of 266.44K shares and market capitalization of 3.06B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 21000 people. Amedisys Inc CEO is Paul B. Kusserow.

The one-year performance of Amedisys Inc stock is -13.22%, while year-to-date (YTD) performance is 12.43%. AMED stock has a five-year performance of -20.78%. Its 52-week range is between 69.365 and 115.5, which gives AMED stock a 52-week price range ratio of 53.22%

Amedisys Inc currently has a PE ratio of 22.30, a price-to-book (PB) ratio of 2.64, a price-to-sale (PS) ratio of 1.60, a price to cashflow ratio of 27.70, a PEG ratio of 2.69, a ROA of 6.68%, a ROC of 8.90% and a ROE of 13.57%. The company’s profit margin is 5.19%, its EBITDA margin is 11.70%, and its revenue ttm is $1.66 Billion , which makes it $51.12 revenue per share.

Of the last four earnings reports from Amedisys Inc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.08 for the next earnings report. Amedisys Inc’s next earnings report date is 25th Oct 2023.

The consensus rating of Wall Street analysts for Amedisys Inc is Hold (2.77), with a target price of $121.43, which is +29.29% compared to the current price. The earnings rating for Amedisys Inc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amedisys Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amedisys Inc has a Buy technical analysis rating based on Technical Indicators (ADX : 20.07, ATR14 : 0.57, CCI20 : 40.60, Chaikin Money Flow : 0.00, MACD : 0.39, Money Flow Index : 46.02, ROC : 0.59, RSI : 59.94, STOCH (14,3) : 80.79, STOCH RSI : 0.46, UO : 59.41, Williams %R : -19.21), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amedisys Inc in the last 12-months were: Michael North (Sold 5 908 shares of value $510 628 ), North Michael (Sold 5 908 shares of value $510 628 ), Paul B. Kusserow (Option Excercise at a value of $0)